COMMUNIQUÉS West-GlobeNewswire

-
Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
13/03/2024 -
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland
13/03/2024 -
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
13/03/2024 -
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
13/03/2024 -
Liberation Labs Taps Biotech Biomanufacturing Veteran Rhys Dale to Assist with Development & Operations of Flagship Facility
13/03/2024 -
Annual General Meeting 2024 – GN Store Nord A/S
13/03/2024 -
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
13/03/2024 -
Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410
13/03/2024 -
3Daughters Announces Three New Appointments to Board of Directors
13/03/2024 -
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
13/03/2024 -
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
13/03/2024 -
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
13/03/2024 -
HealthLynked Welcomes David Rosal as New Chief Financial Officer
13/03/2024 -
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
13/03/2024 -
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
13/03/2024 -
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
13/03/2024 -
Recce Pharmaceuticals to Present at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting
13/03/2024 -
IMUNON Files IND Application to Begin Human Testing of IMNN-101
13/03/2024 -
INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy
13/03/2024
Pages